nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—lung cancer	0.304	1	CbGaD
Lisinopril—ABCB1—Topotecan—lung cancer	0.0488	0.136	CbGbCtD
Lisinopril—ABCB1—Gefitinib—lung cancer	0.0446	0.124	CbGbCtD
Lisinopril—ABCB1—Vinorelbine—lung cancer	0.0344	0.0958	CbGbCtD
Lisinopril—ABCB1—Crizotinib—lung cancer	0.0274	0.0762	CbGbCtD
Lisinopril—ABCB1—Gemcitabine—lung cancer	0.0267	0.0745	CbGbCtD
Lisinopril—ABCB1—Erlotinib—lung cancer	0.0264	0.0735	CbGbCtD
Lisinopril—ABCB1—Paclitaxel—lung cancer	0.0242	0.0673	CbGbCtD
Lisinopril—ABCB1—Irinotecan—lung cancer	0.0238	0.0664	CbGbCtD
Lisinopril—ABCB1—Vinblastine—lung cancer	0.0212	0.059	CbGbCtD
Lisinopril—ABCB1—Cisplatin—lung cancer	0.0194	0.0541	CbGbCtD
Lisinopril—ABCB1—Etoposide—lung cancer	0.0191	0.0532	CbGbCtD
Lisinopril—ABCB1—Docetaxel—lung cancer	0.0175	0.0486	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—lung cancer	0.013	0.0363	CbGbCtD
Lisinopril—ABCB1—Methotrexate—lung cancer	0.0126	0.0351	CbGbCtD
Lisinopril—ACE—pulmonary artery—lung cancer	0.0118	0.244	CbGeAlD
Lisinopril—ACE—umbilical vein—lung cancer	0.00782	0.161	CbGeAlD
Lisinopril—ACE2—respiratory system—lung cancer	0.00609	0.125	CbGeAlD
Lisinopril—ACE2—cardiac atrium—lung cancer	0.00423	0.0871	CbGeAlD
Lisinopril—ACE2—lung—lung cancer	0.00323	0.0666	CbGeAlD
Lisinopril—SLC15A1—epithelium—lung cancer	0.00232	0.0478	CbGeAlD
Lisinopril—ACE2—lymph node—lung cancer	0.00221	0.0455	CbGeAlD
Lisinopril—ACE—respiratory system—lung cancer	0.00199	0.041	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—KIF5B—lung cancer	0.00191	0.0969	CbGpPWpGaD
Lisinopril—ACE—epithelium—lung cancer	0.00166	0.0343	CbGeAlD
Lisinopril—ACE—cardiac atrium—lung cancer	0.00138	0.0285	CbGeAlD
Lisinopril—ACE—bone marrow—lung cancer	0.00117	0.024	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—GRP—lung cancer	0.00115	0.0584	CbGpPWpGaD
Lisinopril—ACE—lung—lung cancer	0.00106	0.0218	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—KIF5B—lung cancer	0.000851	0.0433	CbGpPWpGaD
Lisinopril—ABCB1—Abacavir transmembrane transport—ABCG2—lung cancer	0.000816	0.0415	CbGpPWpGaD
Lisinopril—ACE—lymph node—lung cancer	0.000723	0.0149	CbGeAlD
Lisinopril—ABCB1—respiratory system—lung cancer	0.000701	0.0144	CbGeAlD
Lisinopril—ABCB1—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.000687	0.0349	CbGpPWpGaD
Lisinopril—ABCB1—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.000646	0.0328	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.000618	0.0314	CbGpPWpGaD
Lisinopril—ABCB1—epithelium—lung cancer	0.000586	0.0121	CbGeAlD
Lisinopril—ABCB1—trachea—lung cancer	0.000518	0.0107	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—GRP—lung cancer	0.000513	0.0261	CbGpPWpGaD
Lisinopril—ABCB1—Abacavir transport and metabolism—ABCG2—lung cancer	0.000468	0.0238	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EIF2B4—lung cancer	0.000458	0.0233	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—POMC—lung cancer	0.000414	0.021	CbGpPWpGaD
Lisinopril—ABCB1—bone marrow—lung cancer	0.000411	0.00846	CbGeAlD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000376	0.0191	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—KHSRP—lung cancer	0.000374	0.019	CbGpPWpGaD
Lisinopril—ABCB1—lung—lung cancer	0.000372	0.00766	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—KIF5B—lung cancer	0.00036	0.0183	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—EIF2B5—lung cancer	0.000327	0.0166	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ST3GAL5—lung cancer	0.000278	0.0141	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000276	0.014	CbGpPWpGaD
Lisinopril—ABCB1—lymph node—lung cancer	0.000254	0.00524	CbGeAlD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—HMGB2—lung cancer	0.00025	0.0127	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—B4GALT5—lung cancer	0.000248	0.0126	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ADAMTS1—lung cancer	0.000248	0.0126	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000238	0.0121	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000227	0.0115	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—GRP—lung cancer	0.000217	0.011	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000216	0.011	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000213	0.0108	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000209	0.0106	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCC3—lung cancer	0.000206	0.0105	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EIF2B4—lung cancer	0.000205	0.0104	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000197	0.01	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ATF3—lung cancer	0.000189	0.00961	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—POMC—lung cancer	0.000185	0.0094	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000174	0.00883	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LMNA—lung cancer	0.00017	0.00863	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—KHSRP—lung cancer	0.000167	0.00849	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—KIF5B—lung cancer	0.000161	0.00817	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—lung cancer	0.000149	0.00759	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—MCL1—lung cancer	0.000149	0.00759	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—EIF2B5—lung cancer	0.000146	0.00742	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000141	0.00715	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00014	0.00714	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—lung cancer	0.000131	0.00668	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ST3GAL5—lung cancer	0.000124	0.00631	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—lung cancer	0.000111	0.00565	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—B4GALT5—lung cancer	0.000111	0.00562	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ADAMTS1—lung cancer	0.000111	0.00562	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ALDOA—lung cancer	0.00011	0.00557	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000106	0.00541	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ABCG2—lung cancer	0.000104	0.00526	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GRP—lung cancer	9.69e-05	0.00492	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TF—lung cancer	9.62e-05	0.00489	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP1—lung cancer	9.4e-05	0.00478	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ENO1—lung cancer	9.23e-05	0.00469	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	9.03e-05	0.00459	CbGpPWpGaD
Lisinopril—Dysuria—Doxorubicin—lung cancer	8.44e-05	0.000314	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—lung cancer	8.44e-05	0.000314	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—ATF3—lung cancer	8.44e-05	0.00429	CbGpPWpGaD
Lisinopril—Decreased appetite—Paclitaxel—lung cancer	8.44e-05	0.000314	CcSEcCtD
Lisinopril—Dry mouth—Docetaxel—lung cancer	8.39e-05	0.000313	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—lung cancer	8.39e-05	0.000312	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Paclitaxel—lung cancer	8.38e-05	0.000312	CcSEcCtD
Lisinopril—Fatigue—Paclitaxel—lung cancer	8.37e-05	0.000312	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—lung cancer	8.35e-05	0.000311	CcSEcCtD
Lisinopril—Asthenia—Gemcitabine—lung cancer	8.32e-05	0.00031	CcSEcCtD
Lisinopril—Pain—Paclitaxel—lung cancer	8.3e-05	0.000309	CcSEcCtD
Lisinopril—Constipation—Paclitaxel—lung cancer	8.3e-05	0.000309	CcSEcCtD
Lisinopril—Confusional state—Docetaxel—lung cancer	8.3e-05	0.000309	CcSEcCtD
Lisinopril—ABCB1—ABC-family proteins mediated transport—APOA1—lung cancer	8.28e-05	0.00421	CbGpPWpGaD
Lisinopril—Pharyngitis—Methotrexate—lung cancer	8.28e-05	0.000308	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—lung cancer	8.24e-05	0.000307	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—lung cancer	8.24e-05	0.000307	CcSEcCtD
Lisinopril—Oedema—Docetaxel—lung cancer	8.23e-05	0.000306	CcSEcCtD
Lisinopril—Anaphylactic shock—Docetaxel—lung cancer	8.23e-05	0.000306	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—lung cancer	8.22e-05	0.000306	CcSEcCtD
Lisinopril—Pruritus—Gemcitabine—lung cancer	8.2e-05	0.000305	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—lung cancer	8.18e-05	0.000305	CcSEcCtD
Lisinopril—Infection—Docetaxel—lung cancer	8.17e-05	0.000304	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—lung cancer	8.17e-05	0.000304	CcSEcCtD
Lisinopril—Feeling abnormal—Etoposide—lung cancer	8.16e-05	0.000304	CcSEcCtD
Lisinopril—Hyperglycaemia—Doxorubicin—lung cancer	8.15e-05	0.000303	CcSEcCtD
Lisinopril—Diarrhoea—Irinotecan—lung cancer	8.14e-05	0.000303	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—lung cancer	8.1e-05	0.000302	CcSEcCtD
Lisinopril—Gastrointestinal pain—Etoposide—lung cancer	8.1e-05	0.000301	CcSEcCtD
Lisinopril—Shock—Docetaxel—lung cancer	8.09e-05	0.000301	CcSEcCtD
Lisinopril—Thrombocytopenia—Docetaxel—lung cancer	8.06e-05	0.0003	CcSEcCtD
Lisinopril—Tachycardia—Docetaxel—lung cancer	8.03e-05	0.000299	CcSEcCtD
Lisinopril—Feeling abnormal—Paclitaxel—lung cancer	8e-05	0.000298	CcSEcCtD
Lisinopril—Skin disorder—Docetaxel—lung cancer	7.99e-05	0.000298	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.98e-05	0.000297	CcSEcCtD
Lisinopril—Hypersensitivity—Cisplatin—lung cancer	7.96e-05	0.000296	CcSEcCtD
Lisinopril—Gastrointestinal pain—Paclitaxel—lung cancer	7.94e-05	0.000296	CcSEcCtD
Lisinopril—Diarrhoea—Gemcitabine—lung cancer	7.93e-05	0.000295	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—lung cancer	7.91e-05	0.000295	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—lung cancer	7.89e-05	0.000294	CcSEcCtD
Lisinopril—Neuropathy peripheral—Doxorubicin—lung cancer	7.89e-05	0.000294	CcSEcCtD
Lisinopril—Dizziness—Irinotecan—lung cancer	7.87e-05	0.000293	CcSEcCtD
Lisinopril—Urticaria—Etoposide—lung cancer	7.86e-05	0.000293	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—lung cancer	7.85e-05	0.000292	CcSEcCtD
Lisinopril—Anorexia—Docetaxel—lung cancer	7.84e-05	0.000292	CcSEcCtD
Lisinopril—Body temperature increased—Etoposide—lung cancer	7.83e-05	0.000291	CcSEcCtD
Lisinopril—Abdominal pain—Etoposide—lung cancer	7.83e-05	0.000291	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—lung cancer	7.83e-05	0.000291	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—POMC—lung cancer	7.82e-05	0.00397	CbGpPWpGaD
Lisinopril—Tinnitus—Methotrexate—lung cancer	7.78e-05	0.00029	CcSEcCtD
Lisinopril—Asthenia—Cisplatin—lung cancer	7.75e-05	0.000289	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—lung cancer	7.72e-05	0.000287	CcSEcCtD
Lisinopril—Urticaria—Paclitaxel—lung cancer	7.71e-05	0.000287	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	7.7e-05	0.00392	CbGpPWpGaD
Lisinopril—Hypotension—Docetaxel—lung cancer	7.69e-05	0.000286	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—lung cancer	7.68e-05	0.000286	CcSEcCtD
Lisinopril—Abdominal pain—Paclitaxel—lung cancer	7.67e-05	0.000286	CcSEcCtD
Lisinopril—Body temperature increased—Paclitaxel—lung cancer	7.67e-05	0.000286	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—lung cancer	7.61e-05	0.000283	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—lung cancer	7.59e-05	0.000283	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—LMNA—lung cancer	7.58e-05	0.00385	CbGpPWpGaD
Lisinopril—Angiopathy—Methotrexate—lung cancer	7.57e-05	0.000282	CcSEcCtD
Lisinopril—Vomiting—Irinotecan—lung cancer	7.57e-05	0.000282	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—lung cancer	7.55e-05	0.000281	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—lung cancer	7.52e-05	0.00028	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—lung cancer	7.51e-05	0.00028	CcSEcCtD
Lisinopril—Rash—Irinotecan—lung cancer	7.5e-05	0.000279	CcSEcCtD
Lisinopril—Dermatitis—Irinotecan—lung cancer	7.5e-05	0.000279	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Docetaxel—lung cancer	7.5e-05	0.000279	CcSEcCtD
Lisinopril—Chills—Methotrexate—lung cancer	7.49e-05	0.000279	CcSEcCtD
Lisinopril—Headache—Irinotecan—lung cancer	7.46e-05	0.000278	CcSEcCtD
Lisinopril—Insomnia—Docetaxel—lung cancer	7.44e-05	0.000277	CcSEcCtD
Lisinopril—Diarrhoea—Cisplatin—lung cancer	7.39e-05	0.000275	CcSEcCtD
Lisinopril—Paraesthesia—Docetaxel—lung cancer	7.39e-05	0.000275	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—lung cancer	7.38e-05	0.000275	CcSEcCtD
Lisinopril—Vomiting—Gemcitabine—lung cancer	7.37e-05	0.000274	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—lung cancer	7.36e-05	0.000274	CcSEcCtD
Lisinopril—Dyspnoea—Docetaxel—lung cancer	7.34e-05	0.000273	CcSEcCtD
Lisinopril—Somnolence—Docetaxel—lung cancer	7.31e-05	0.000272	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—lung cancer	7.31e-05	0.000272	CcSEcCtD
Lisinopril—Rash—Gemcitabine—lung cancer	7.31e-05	0.000272	CcSEcCtD
Lisinopril—Dermatitis—Gemcitabine—lung cancer	7.3e-05	0.000272	CcSEcCtD
Lisinopril—Hypersensitivity—Etoposide—lung cancer	7.29e-05	0.000272	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—MMP2—lung cancer	7.28e-05	0.0037	CbGpPWpGaD
Lisinopril—Malnutrition—Methotrexate—lung cancer	7.27e-05	0.000271	CcSEcCtD
Lisinopril—Erythema—Methotrexate—lung cancer	7.27e-05	0.000271	CcSEcCtD
Lisinopril—Headache—Gemcitabine—lung cancer	7.26e-05	0.00027	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—lung cancer	7.25e-05	0.00027	CcSEcCtD
Lisinopril—Dyspepsia—Docetaxel—lung cancer	7.24e-05	0.00027	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—lung cancer	7.23e-05	0.000269	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—lung cancer	7.17e-05	0.000267	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—lung cancer	7.15e-05	0.000266	CcSEcCtD
Lisinopril—Hypersensitivity—Paclitaxel—lung cancer	7.15e-05	0.000266	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—lung cancer	7.14e-05	0.000266	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—lung cancer	7.12e-05	0.000265	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—lung cancer	7.12e-05	0.000265	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—lung cancer	7.1e-05	0.000264	CcSEcCtD
Lisinopril—Asthenia—Etoposide—lung cancer	7.1e-05	0.000264	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—lung cancer	7.09e-05	0.000264	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—lung cancer	7.08e-05	0.000264	CcSEcCtD
Lisinopril—Nausea—Irinotecan—lung cancer	7.07e-05	0.000263	CcSEcCtD
Lisinopril—Pain—Docetaxel—lung cancer	7.04e-05	0.000262	CcSEcCtD
Lisinopril—Constipation—Docetaxel—lung cancer	7.04e-05	0.000262	CcSEcCtD
Lisinopril—Back pain—Methotrexate—lung cancer	7.03e-05	0.000262	CcSEcCtD
Lisinopril—Pruritus—Etoposide—lung cancer	7e-05	0.000261	CcSEcCtD
Lisinopril—Asthenia—Paclitaxel—lung cancer	6.96e-05	0.000259	CcSEcCtD
Lisinopril—Nausea—Gemcitabine—lung cancer	6.89e-05	0.000256	CcSEcCtD
Lisinopril—Vomiting—Cisplatin—lung cancer	6.87e-05	0.000256	CcSEcCtD
Lisinopril—Pruritus—Paclitaxel—lung cancer	6.87e-05	0.000256	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—lung cancer	6.85e-05	0.000255	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—lung cancer	6.83e-05	0.000254	CcSEcCtD
Lisinopril—Rash—Cisplatin—lung cancer	6.81e-05	0.000254	CcSEcCtD
Lisinopril—Dermatitis—Cisplatin—lung cancer	6.81e-05	0.000253	CcSEcCtD
Lisinopril—Feeling abnormal—Docetaxel—lung cancer	6.78e-05	0.000252	CcSEcCtD
Lisinopril—Diarrhoea—Etoposide—lung cancer	6.77e-05	0.000252	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—lung cancer	6.74e-05	0.000251	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—lung cancer	6.74e-05	0.000251	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	6.73e-05	0.00342	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Docetaxel—lung cancer	6.73e-05	0.00025	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—lung cancer	6.72e-05	0.00025	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—lung cancer	6.71e-05	0.00025	CcSEcCtD
Lisinopril—Diarrhoea—Paclitaxel—lung cancer	6.64e-05	0.000247	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—AVP—lung cancer	6.59e-05	0.00335	CbGpPWpGaD
Lisinopril—Angiopathy—Doxorubicin—lung cancer	6.56e-05	0.000244	CcSEcCtD
Lisinopril—Malaise—Methotrexate—lung cancer	6.55e-05	0.000244	CcSEcCtD
Lisinopril—Dizziness—Etoposide—lung cancer	6.55e-05	0.000244	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—lung cancer	6.53e-05	0.000243	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—lung cancer	6.51e-05	0.000243	CcSEcCtD
Lisinopril—Abdominal pain—Docetaxel—lung cancer	6.5e-05	0.000242	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—lung cancer	6.5e-05	0.000242	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—lung cancer	6.5e-05	0.000242	CcSEcCtD
Lisinopril—Chills—Doxorubicin—lung cancer	6.48e-05	0.000241	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—lung cancer	6.46e-05	0.00024	CcSEcCtD
Lisinopril—Dizziness—Paclitaxel—lung cancer	6.42e-05	0.000239	CcSEcCtD
Lisinopril—Nausea—Cisplatin—lung cancer	6.42e-05	0.000239	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—lung cancer	6.39e-05	0.000238	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	6.38e-05	0.00325	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	6.38e-05	0.00325	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCC3—lung cancer	6.37e-05	0.00324	CbGpPWpGaD
Lisinopril—Cough—Methotrexate—lung cancer	6.34e-05	0.000236	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—lung cancer	6.33e-05	0.000236	CcSEcCtD
Lisinopril—Vomiting—Etoposide—lung cancer	6.29e-05	0.000234	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—lung cancer	6.29e-05	0.000234	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—lung cancer	6.29e-05	0.000234	CcSEcCtD
Lisinopril—Rash—Etoposide—lung cancer	6.24e-05	0.000232	CcSEcCtD
Lisinopril—Dermatitis—Etoposide—lung cancer	6.24e-05	0.000232	CcSEcCtD
Lisinopril—Headache—Etoposide—lung cancer	6.2e-05	0.000231	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—lung cancer	6.2e-05	0.000231	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—lung cancer	6.19e-05	0.00023	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—lung cancer	6.19e-05	0.00023	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—lung cancer	6.19e-05	0.00023	CcSEcCtD
Lisinopril—Tension—Doxorubicin—lung cancer	6.17e-05	0.00023	CcSEcCtD
Lisinopril—Vomiting—Paclitaxel—lung cancer	6.17e-05	0.00023	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—lung cancer	6.16e-05	0.000229	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.14e-05	0.000229	CcSEcCtD
Lisinopril—Rash—Paclitaxel—lung cancer	6.12e-05	0.000228	CcSEcCtD
Lisinopril—Dermatitis—Paclitaxel—lung cancer	6.11e-05	0.000228	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—lung cancer	6.11e-05	0.000228	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—lung cancer	6.11e-05	0.000228	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—lung cancer	6.09e-05	0.000227	CcSEcCtD
Lisinopril—Headache—Paclitaxel—lung cancer	6.08e-05	0.000226	CcSEcCtD
Lisinopril—Hypersensitivity—Docetaxel—lung cancer	6.06e-05	0.000226	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—lung cancer	6.05e-05	0.000225	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—lung cancer	6.05e-05	0.00307	CbGpPWpGaD
Lisinopril—Confusional state—Methotrexate—lung cancer	5.98e-05	0.000223	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—lung cancer	5.93e-05	0.000221	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—lung cancer	5.93e-05	0.000221	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	5.91e-05	0.003	CbGpPWpGaD
Lisinopril—Asthenia—Docetaxel—lung cancer	5.9e-05	0.00022	CcSEcCtD
Lisinopril—Infection—Methotrexate—lung cancer	5.89e-05	0.000219	CcSEcCtD
Lisinopril—Nausea—Etoposide—lung cancer	5.88e-05	0.000219	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—lung cancer	5.84e-05	0.000217	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—lung cancer	5.82e-05	0.000217	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—lung cancer	5.82e-05	0.000217	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—lung cancer	5.81e-05	0.000216	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GNG11—lung cancer	5.78e-05	0.00294	CbGpPWpGaD
Lisinopril—Nausea—Paclitaxel—lung cancer	5.77e-05	0.000215	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—lung cancer	5.76e-05	0.000214	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—lung cancer	5.73e-05	0.000213	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—lung cancer	5.67e-05	0.000211	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—lung cancer	5.65e-05	0.00021	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—lung cancer	5.65e-05	0.00021	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—lung cancer	5.64e-05	0.00021	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—lung cancer	5.63e-05	0.00021	CcSEcCtD
Lisinopril—Diarrhoea—Docetaxel—lung cancer	5.63e-05	0.00021	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—lung cancer	5.56e-05	0.000207	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—lung cancer	5.54e-05	0.000206	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—lung cancer	5.53e-05	0.000206	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	5.53e-05	0.00281	CbGpPWpGaD
Lisinopril—Cough—Doxorubicin—lung cancer	5.49e-05	0.000204	CcSEcCtD
Lisinopril—Dizziness—Docetaxel—lung cancer	5.44e-05	0.000203	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL10—lung cancer	5.43e-05	0.00276	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Methotrexate—lung cancer	5.4e-05	0.000201	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—lung cancer	5.36e-05	0.0002	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—lung cancer	5.36e-05	0.000199	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—lung cancer	5.36e-05	0.000199	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—lung cancer	5.36e-05	0.000199	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—lung cancer	5.34e-05	0.000199	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—lung cancer	5.32e-05	0.000198	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.32e-05	0.000198	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—lung cancer	5.29e-05	0.000197	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—lung cancer	5.29e-05	0.000197	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	5.29e-05	0.00269	CbGpPWpGaD
Lisinopril—Somnolence—Methotrexate—lung cancer	5.27e-05	0.000196	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—lung cancer	5.24e-05	0.000195	CcSEcCtD
Lisinopril—Vomiting—Docetaxel—lung cancer	5.23e-05	0.000195	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—lung cancer	5.22e-05	0.000194	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ADCY1—lung cancer	5.2e-05	0.00264	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCG2—lung cancer	5.2e-05	0.00264	CbGpPWpGaD
Lisinopril—Rash—Docetaxel—lung cancer	5.19e-05	0.000193	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—lung cancer	5.18e-05	0.000193	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—lung cancer	5.18e-05	0.000193	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—lung cancer	5.15e-05	0.000192	CcSEcCtD
Lisinopril—Headache—Docetaxel—lung cancer	5.15e-05	0.000192	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—lung cancer	5.13e-05	0.000191	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—lung cancer	5.13e-05	0.000191	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—lung cancer	5.12e-05	0.000191	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—lung cancer	5.11e-05	0.00019	CcSEcCtD
Lisinopril—Infection—Doxorubicin—lung cancer	5.1e-05	0.00019	CcSEcCtD
Lisinopril—Pain—Methotrexate—lung cancer	5.07e-05	0.000189	CcSEcCtD
Lisinopril—Shock—Doxorubicin—lung cancer	5.05e-05	0.000188	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—FASLG—lung cancer	5.05e-05	0.00257	CbGpPWpGaD
Lisinopril—Thrombocytopenia—Doxorubicin—lung cancer	5.03e-05	0.000187	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—lung cancer	5.01e-05	0.000187	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—lung cancer	4.99e-05	0.000186	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	4.96e-05	0.00252	CbGpPWpGaD
Lisinopril—Hyperhidrosis—Doxorubicin—lung cancer	4.96e-05	0.000185	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—lung cancer	4.89e-05	0.000182	CcSEcCtD
Lisinopril—Nausea—Docetaxel—lung cancer	4.89e-05	0.000182	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—lung cancer	4.89e-05	0.000182	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—lung cancer	4.85e-05	0.000181	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TF—lung cancer	4.83e-05	0.00246	CbGpPWpGaD
Lisinopril—Hypotension—Doxorubicin—lung cancer	4.8e-05	0.000179	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	4.75e-05	0.00241	CbGpPWpGaD
Lisinopril—Urticaria—Methotrexate—lung cancer	4.71e-05	0.000175	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—lung cancer	4.69e-05	0.000175	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—lung cancer	4.69e-05	0.000175	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.68e-05	0.000174	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—lung cancer	4.64e-05	0.000173	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—lung cancer	4.61e-05	0.000172	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—lung cancer	4.58e-05	0.00017	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—lung cancer	4.56e-05	0.00017	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—lung cancer	4.52e-05	0.000168	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—lung cancer	4.46e-05	0.000166	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—lung cancer	4.43e-05	0.000165	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—lung cancer	4.43e-05	0.000165	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—lung cancer	4.39e-05	0.000163	CcSEcCtD
Lisinopril—Pain—Doxorubicin—lung cancer	4.39e-05	0.000163	CcSEcCtD
Lisinopril—Hypersensitivity—Methotrexate—lung cancer	4.37e-05	0.000163	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	4.34e-05	0.00221	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	4.32e-05	0.0022	CbGpPWpGaD
Lisinopril—Asthenia—Methotrexate—lung cancer	4.25e-05	0.000158	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—lung cancer	4.23e-05	0.000158	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—MMP1—lung cancer	4.2e-05	0.00214	CbGpPWpGaD
Lisinopril—Gastrointestinal pain—Doxorubicin—lung cancer	4.2e-05	0.000156	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—lung cancer	4.2e-05	0.000156	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—lung cancer	4.08e-05	0.000152	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—lung cancer	4.06e-05	0.000151	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—lung cancer	4.06e-05	0.000151	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—lung cancer	4.06e-05	0.000151	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—lung cancer	3.99e-05	0.00203	CbGpPWpGaD
Lisinopril—Dizziness—Methotrexate—lung cancer	3.92e-05	0.000146	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	3.87e-05	0.00197	CbGpPWpGaD
Lisinopril—Hypersensitivity—Doxorubicin—lung cancer	3.78e-05	0.000141	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—lung cancer	3.77e-05	0.00014	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CASP8—lung cancer	3.76e-05	0.00191	CbGpPWpGaD
Lisinopril—Rash—Methotrexate—lung cancer	3.74e-05	0.000139	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—lung cancer	3.74e-05	0.000139	CcSEcCtD
Lisinopril—Headache—Methotrexate—lung cancer	3.71e-05	0.000138	CcSEcCtD
Lisinopril—Asthenia—Doxorubicin—lung cancer	3.68e-05	0.000137	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	3.67e-05	0.00186	CbGpPWpGaD
Lisinopril—Pruritus—Doxorubicin—lung cancer	3.63e-05	0.000135	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	3.6e-05	0.00183	CbGpPWpGaD
Lisinopril—Nausea—Methotrexate—lung cancer	3.52e-05	0.000131	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—lung cancer	3.51e-05	0.000131	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—POMC—lung cancer	3.49e-05	0.00177	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	3.47e-05	0.00177	CbGpPWpGaD
Lisinopril—Dizziness—Doxorubicin—lung cancer	3.4e-05	0.000126	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—AVP—lung cancer	3.35e-05	0.0017	CbGpPWpGaD
Lisinopril—Vomiting—Doxorubicin—lung cancer	3.26e-05	0.000122	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	3.25e-05	0.00165	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP2—lung cancer	3.25e-05	0.00165	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—lung cancer	3.24e-05	0.00165	CbGpPWpGaD
Lisinopril—Rash—Doxorubicin—lung cancer	3.24e-05	0.000121	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—lung cancer	3.23e-05	0.00012	CcSEcCtD
Lisinopril—Headache—Doxorubicin—lung cancer	3.22e-05	0.00012	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	3.19e-05	0.00162	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	3.15e-05	0.0016	CbGpPWpGaD
Lisinopril—Nausea—Doxorubicin—lung cancer	3.05e-05	0.000114	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—lung cancer	2.97e-05	0.00151	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	2.94e-05	0.0015	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP3—lung cancer	2.84e-05	0.00145	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL2—lung cancer	2.84e-05	0.00144	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	2.79e-05	0.00142	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	2.71e-05	0.00138	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CXCL8—lung cancer	2.7e-05	0.00137	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—lung cancer	2.56e-05	0.0013	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	2.49e-05	0.00127	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AZIN2—lung cancer	2.43e-05	0.00124	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—COL4A3BP—lung cancer	2.43e-05	0.00124	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—lung cancer	2.41e-05	0.00123	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	2.29e-05	0.00117	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.17e-05	0.0011	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	2.15e-05	0.0011	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ATP5H—lung cancer	2.07e-05	0.00105	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—lung cancer	2.03e-05	0.00103	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	1.99e-05	0.00101	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	1.97e-05	0.001	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	1.95e-05	0.000993	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	1.85e-05	0.000942	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	1.85e-05	0.000938	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLBD1—lung cancer	1.84e-05	0.000936	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RAF1—lung cancer	1.83e-05	0.000933	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.78e-05	0.000903	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	1.76e-05	0.000895	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	1.76e-05	0.000893	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	1.76e-05	0.000893	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD17B10—lung cancer	1.68e-05	0.000857	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.63e-05	0.00083	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.57e-05	0.000797	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CKB—lung cancer	1.57e-05	0.000796	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.56e-05	0.000794	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.55e-05	0.000786	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.51e-05	0.000768	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM2—lung cancer	1.47e-05	0.000749	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CNDP2—lung cancer	1.47e-05	0.000749	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTMR3—lung cancer	1.43e-05	0.000728	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.4e-05	0.000713	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PGAM1—lung cancer	1.4e-05	0.00071	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.37e-05	0.000694	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.36e-05	0.000693	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2A7—lung cancer	1.33e-05	0.000677	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.32e-05	0.000672	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.32e-05	0.00067	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SDC4—lung cancer	1.3e-05	0.000663	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.26e-05	0.000639	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.22e-05	0.000621	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.19e-05	0.000605	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—RRM1—lung cancer	1.19e-05	0.000603	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA3—lung cancer	1.19e-05	0.000603	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.13e-05	0.000575	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.13e-05	0.000572	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—B4GALT5—lung cancer	1.12e-05	0.000567	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.1e-05	0.000557	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA4—lung cancer	1.09e-05	0.000552	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.07e-05	0.000545	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA2—lung cancer	1.06e-05	0.000538	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTA1—lung cancer	1.02e-05	0.000519	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.01e-05	0.000514	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCC3—lung cancer	1.01e-05	0.000513	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKR1C1—lung cancer	9.78e-06	0.000497	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UGT1A1—lung cancer	9.49e-06	0.000482	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	9.3e-06	0.000473	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNG11—lung cancer	9.15e-06	0.000465	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	8.99e-06	0.000457	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDOA—lung cancer	8.71e-06	0.000443	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	8.66e-06	0.00044	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA3—lung cancer	8.46e-06	0.00043	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCG2—lung cancer	8.23e-06	0.000418	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADCY1—lung cancer	8.23e-06	0.000418	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ENO2—lung cancer	8.07e-06	0.00041	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HPGDS—lung cancer	8.07e-06	0.00041	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPP2R1B—lung cancer	8.02e-06	0.000408	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTT1—lung cancer	7.83e-06	0.000398	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCLC—lung cancer	7.74e-06	0.000393	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2A6—lung cancer	7.74e-06	0.000393	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	7.6e-06	0.000386	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ENO1—lung cancer	7.33e-06	0.000373	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	7.33e-06	0.000373	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	6.86e-06	0.000349	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2E1—lung cancer	6.58e-06	0.000334	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NQO1—lung cancer	6.5e-06	0.000331	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.2e-06	0.000315	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STK11—lung cancer	5.86e-06	0.000298	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTP1—lung cancer	5.42e-06	0.000276	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAT—lung cancer	5.28e-06	0.000268	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TYMS—lung cancer	5.04e-06	0.000256	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM1—lung cancer	4.98e-06	0.000253	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1A1—lung cancer	4.73e-06	0.00024	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ERCC2—lung cancer	4.69e-06	0.000238	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA1—lung cancer	4.05e-06	0.000206	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CG—lung cancer	3.7e-06	0.000188	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—POMC—lung cancer	3.52e-06	0.000179	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CREBBP—lung cancer	3.43e-06	0.000174	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CD—lung cancer	3.25e-06	0.000165	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—lung cancer	3.21e-06	0.000163	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CB—lung cancer	2.84e-06	0.000144	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—lung cancer	2.81e-06	0.000143	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTEN—lung cancer	2.45e-06	0.000125	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—EP300—lung cancer	2.34e-06	0.000119	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—lung cancer	1.73e-06	8.79e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—lung cancer	1.41e-06	7.18e-05	CbGpPWpGaD
